Should cannabidiol be down-scheduled to S3?

The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.

Top five pharmacy Budget asks

The PSA has provided a blueprint to help Federal Treasurer Jim Chalmers improve primary care and enhance medicine safety for all Australians.

How to step up health advice as travel booms

As we approach the holiday season, now is the time to help patients factor health into their travel plans.

Antibiotic prescribing is reaching dangerous levels, warns report

Antibiotic use has crept back up since COVID-19 restrictions have lifted, with multi-resistant bugs increasingly in our midst.

Breathing change into asthma care

Updated guidelines in the Australian Asthma Handbook were released in September 2025 with SABA-only therapy now considered risky in adults and adolescents.

Missing conversations

Patients are being harmed because we are not talking about the adverse effects of mental health medicines.